Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-HALOPERIDOL LA INJECTABLE 50 MG

HALOPERIDOL (HALOPERIDOL DECANOATE) : 50 MG · DIN 02242361 · APOTEX INC

Health Canada status: CANCELLED POST MARKET

What is APO-HALOPERIDOL LA INJECTABLE?

APO-HALOPERIDOL LA INJECTABLE 50 MG contains HALOPERIDOL (HALOPERIDOL DECANOATE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02242361, held by APOTEX INC, supplied as LIQUID for INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02242361
Brand nameAPO-HALOPERIDOL LA INJECTABLE
Generic / active ingredientHALOPERIDOL (HALOPERIDOL DECANOATE) : 50 MG
ManufacturerAPOTEX INC
Strength50 MG
Dosage formLIQUID
Route of administrationINTRAMUSCULAR
SchedulePrescription
ATC codeN05AD01 HALOPERIDOL
AHFS class28:16.08.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date02-Aug-2013
Original market date2000-06-30 00:00:00

Is HALOPERIDOL in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for APO-HALOPERIDOL LA INJECTABLE

What can be used instead?

Other Canadian products sharing ATC code N05AD01 HALOPERIDOL. 9 of 51 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
HALOPERIDOL INJ 5MG/ML USP5 MGLIQUIDSANDOZ CANADA INCORPORATEDMARKETEDDIN 00808652
HALOPERIDOL INJECTION5 MGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02366010
HALOPERIDOL INJECTION, USP5 MGSOLUTIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02406411
HALOPERIDOL LA100 MGLIQUIDSANDOZ CANADA INCORPORATEDMARKETEDDIN 02130300
TEVA-HALOPERIDOL0.5 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 00363685
TEVA-HALOPERIDOL1 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 00363677
TEVA-HALOPERIDOL10 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 00713449
TEVA-HALOPERIDOL2 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 00363669
TEVA-HALOPERIDOL5 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 00363650
APO HALOPERIDOL TAB 0.5MG.5 MGTABLETAPOTEX INCDORMANTDIN 00396796

Who else supplies HALOPERIDOL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. HALOPERIDOL appears in 2739 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for APO-HALOPERIDOL LA INJECTABLE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for APO-HALOPERIDOL LA INJECTABLE

Health Canada Drug Product Database (DPD), DIN 02242361. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.